FEMKE 30mg film-coated tablets medication leaflet

G03AD02 ulipristal acetate • Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Emergency contraceptives

Ulipristal acetate is a medication primarily used for the treatment of uterine fibroids and as an emergency contraceptive. It is a selective progesterone receptor modulator (SPRM) that works by inhibiting the activity of progesterone, a hormone essential for fibroid growth and ovulation.

In the treatment of uterine fibroids, ulipristal is administered orally, usually in courses lasting several months, to reduce the size of fibroids and associated symptoms such as heavy bleeding and pelvic pain. As an emergency contraceptive, it is used to prevent pregnancy after unprotected sexual intercourse if taken within 120 hours.

Common side effects include headache, nausea, abdominal discomfort, and changes in the menstrual cycle. In rare cases, allergic reactions or liver function impairment may occur.

Ulipristal acetate is an effective and versatile medication used both in the management of uterine fibroids and as a method of emergency contraception.

General data about FEMKE 30mg

Substance: ulipristal acetate

Date of last drug list: 01-01-2022

Commercial code: W68320001

Concentration: 30mg

Pharmaceutical form: film-coated tablets

Quantity: 1

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: HAUPT PHARMA MÜNSTER GMBH - GERMANIA

Holder: VIATRIS LIMITED - IRLANDA

Number: 15169/2023/01

Shelf life: 2 years

Pharmaceutical forms available for ulipristal acetate

Concentrations available for ulipristal acetate

30mg, 5mg

Other substances similar to ulipristal acetate